AKBA
Akebia Therapeutics Inc.
$1.55
+$0.01(+0.65%)
18
Overall
20
Value
16
Tech
--
Quality
Market Cap
$461.74M
Volume
3.18M
52W Range
$1.52 - $4.08
Target Price
$5.40
EPS Estimates Overview
| Current Quarter | $0.01 | Next Quarter | $0.03 |
| Current Year | $0.03 | Next Year | $0.31 |
| QoQ Growth | +200.0% | YoY Growth | +933.3% |
| 3Y EPS CAGR | +42.1% | Target Price | $5.40 |
| Consensus | Buy | Upside | +248.4% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | AKBA | $1.55 | +0.6% | 3.18M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Akebia Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW